InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Mahadevia Ankit, 董事长兼首席执行官. Officer active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 13 reports have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €140k. History available since 26 August 2021. The latest transaction was filed on 28 August 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mahadevia Ankit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
6,572 股@ US$1.976.1% 占其流量Common StockSEC:0000950170-25-112661:0
20,000 股0Common StockSEC:0000950170-25-087021:0
13,959 股@ US$0.784.9% 占其流量Common StockSEC:0000950170-25-014849:0
5,912 股@ US$1.353.4% 占其流量Common StockSEC:0000950170-24-102000:0
20,000 股0Common StockSEC:0000950170-24-066625:0
63,795 股@ US$1.3737.9% 占其流量Common StockSEC:0000950170-24-011496:0
20,000 股0Common StockSEC:0000950170-23-052692:0
9,040 股@ US$1.265.0% 占其流量Common StockSEC:0000950170-23-045442:0
12,286 股@ US$1.819.6% 占其流量Common StockSEC:0000899243-23-004039:0
531,914 股0Common StockSEC:0000899243-23-003939:0
134,168 股0Common StockSEC:0000899243-22-004591:0
8,000 股@ US$5.9022.9% 占其流量Common StockSEC:0000899243-21-050049:0
78,219 股0Common StockSEC:0000899243-21-034502:0
13 条申报中的 13 条
About Mahadevia Ankit
Mahadevia Ankit is President and Chief Executive Officer. He has 13 filings in total. Across the 13 filings reviewed, the most recent activity, between 2021-08-30 and 2025-09-03, shows EUR 0 of purchases and EUR 140003 of sales, with Cession as the modal transaction nature. He is also a director of Spero Therapeutics, Inc. (XNAS).
